4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001613377-17-000035
Options or other derivatives
- CEO / President acquired 21,336 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Equels Thomas K. · CEO / President
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-15 | Grant or award : show line 1 in the form Options to buy Common Stock | +21,336 | $0.29 | $6,187 | 21,336 | D |
Loading xslF345X03/primary_doc.xml…